Skip to main content
. Author manuscript; available in PMC: 2020 Jun 29.
Published in final edited form as: Mov Disord. 2019 Jun 24;34(9):1333–1344. doi: 10.1002/mds.27770

TABLE 1.

Genotypic association of SNPs in SNCA and MAPT with PD risk adjusted by sex, age, and multiple testing adjustments of P values

PD Control


Gene SNP Alleles, M/m Freq. 11 Freq. 12 Freq. 22 Freq. 11 Freq. 12 Freq. 22 OR (95% CI) Model Genotypic P value Adj. Gen. P value

SNCA rs356219 A (1)/G (2) 0.36 0.47 0.17 0.45 0.44 0.11 1.36 (1.18–1.56) Log-additive <.0001 <.0027
MAPT rs1800547 A (1)/G (2) 0.56 0.38 0.06 0.49 0.41 0.11 1.33 (1.15–1.54) Log-additive .0001 .0027
DDIT4L rs1053227 G (1)/A (2) 0.33 0.49 0.18 0.37 0.49 0.14 0.84 (0.73–0.96) Log-additive .0100 1350
EIF4EBP1 rs6605631 T (1)/C (2) 0.69 0.29 0.02 0.66 0.29 0.05 1.98 (1.16–3.38) Recessive .0100 .1350
LPIN1 rs7595221 A (1)/G (2) 0.29 0.48 0.23 0.25 0.53 0.22 1.23 (1.02–1.49) Overdominant .0270 .2916
PRKCA rs887797 G (1)/A (2) 0.48 0.40 0.12 0.43 0.45 0.12 1.22 (1.01–1.48) Overdominant .0360 .2922

Statistically significant P values are bold. Genotypic test calculated in SNPstats software with sex and age adjustment of P values. P values were adjusted for 54 multiple testing by using FDR correction. The genotypic test was chosen as the genetic test model with lower Akaike information/lower P value. N = 898 PD cases; 921 controls (N = 1,819). CI, confidence interval; Freq., frequency; M, major allele; MAPT, microtubule-associated protein Tau; m, minor allele; OR, odds ratio; SNCA, α-synuclein; SNP, single nucleotide polymorphism.